Scientists hunt for clues to pregnancy complications in blood and placenta
NCT ID NCT07464379
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is collecting blood, amniotic fluid, and placenta samples from 100 pregnant women, including those with pregnancy-induced hypertension and those who have had a miscarriage. Researchers will test these samples to look for differences in immune cells and other markers. The goal is to better understand what causes these pregnancy complications, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help researchers better understand the causes of pregnancy-induced hypertension and miscarriage, potentially pointing toward future diagnostic tools or treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (100 participants) and early-stage, so it may not lead to immediate medical advances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY INDUCED HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.